OPK
OPK 50 articles

Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026

globenewswire.com·Jun 15

OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?

zacks.com·May 28

Here's Why You Should Retain OPK Stock in Your Portfolio for Now

zacks.com·May 21

OPKO Health's ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

globenewswire.com·May 12

OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

globenewswire.com·Apr 30

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

globenewswire.com·Apr 30

OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y

zacks.com·Apr 29

OPKO Health, Inc. (OPK) Q1 2026 Earnings Call Transcript

seekingalpha.com·Apr 28

OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

zacks.com·Apr 28

OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates

zacks.com·Apr 28

OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results

globenewswire.com·Apr 28

Financial Survey: OrthoPediatrics (NASDAQ:KIDS) and OPKO Health (NASDAQ:OPK)

defenseworld.net·Apr 24

Here's Why You Should Hold OPK Stock in Your Portfolio for Now

zacks.com·Apr 23

OPKO Health's ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

globenewswire.com·Apr 22

OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026

globenewswire.com·Apr 21

Comparing OPKO Health (NASDAQ:OPK) & ADM Tronics Unlimited (OTCMKTS:ADMT)

defenseworld.net·Apr 17

OPKO Health, Inc. (NASDAQ:OPK) Receives $1.55 Consensus Price Target from Analysts

defenseworld.net·Apr 14

Reviewing PROCEPT BioRobotics (NASDAQ:PRCT) & OPKO Health (NASDAQ:OPK)

defenseworld.net·Apr 6

Analysts Set OPKO Health, Inc. (NASDAQ:OPK) Target Price at $2.03

defenseworld.net·Mar 20

Here's Why You Should Hold OPK Stock in Your Portfolio for Now

zacks.com·Mar 19

Critical Analysis: OPKO Health (NASDAQ:OPK) vs. Hypertension Diagnostics (OTCMKTS:HDII)

defenseworld.net·Mar 16

OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts

zacks.com·Feb 27

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

globenewswire.com·Feb 27

Critical Analysis: OPKO Health (NASDAQ:OPK) vs. Sintx Technologies (NASDAQ:SINT)

defenseworld.net·Feb 27

OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript

seekingalpha.com·Feb 26

Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics

zacks.com·Feb 26

OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates

zacks.com·Feb 26

OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results

globenewswire.com·Feb 26

OPKO Health (OPK) Projected to Post Quarterly Earnings on Thursday

defenseworld.net·Feb 19

Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?

zacks.com·Feb 18

OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26

globenewswire.com·Feb 12

Reviewing OPKO Health (NASDAQ:OPK) and Coloplast A/S (OTCMKTS:CLPBY)

defenseworld.net·Feb 12

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

globenewswire.com·Feb 4

OPKO Health: Deeply Mispriced Ahead Of Major Catalysts

seekingalpha.com·Jan 27

OPKO Health (NASDAQ:OPK) Shares Cross Below Fifty Day Moving Average – Here’s Why

defenseworld.net·Jan 16

OPKO Health (NASDAQ:OPK) & Positron (OTCMKTS:POSC) Head-To-Head Review

defenseworld.net·Jan 16

OPKO Health, Inc. (OPK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

seekingalpha.com·Jan 15

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

globenewswire.com·Jan 6

OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth

zacks.com·Jan 6

Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now

zacks.com·Dec 9

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

globenewswire.com·Nov 19

OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands

zacks.com·Oct 30

OPKO Health, Inc. (OPK) Q3 2025 Earnings Call Transcript

seekingalpha.com·Oct 29

Compared to Estimates, OPKO Health (OPK) Q3 Earnings: A Look at Key Metrics

zacks.com·Oct 29

OPKO Health (OPK) Q3 Earnings Surpass Estimates

zacks.com·Oct 29

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

globenewswire.com·Oct 29

Here's Why You Should Add OPKO Health Stock to Your Portfolio

zacks.com·Oct 23

OPKO Health to Report Third Quarter 2025 Financial Results on October 29

globenewswire.com·Oct 22

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

prnewswire.com·Sep 15

Here's Why You Should Retain OPKO Health Stock in Your Portfolio

zacks.com·Sep 11
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.